BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7957521)

  • 1. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.
    Rochdi M; Sabouraud A; Girre C; Venet R; Scherrmann JM
    Eur J Clin Pharmacol; 1994; 46(4):351-4. PubMed ID: 7957521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses.
    Ferron GM; Rochdi M; Jusko WJ; Scherrmann JM
    J Clin Pharmacol; 1996 Oct; 36(10):874-83. PubMed ID: 8930773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics/bioavailability of colchicine in healthy male volunteers.
    Achtert G; Scherrmann JM; Christen MO
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):317-22. PubMed ID: 2633927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zero-order absorption and linear disposition of oral colchicine in healthy volunteers.
    Thomas G; Girre C; Scherrmann JM; Francheteau P; Steimer JL
    Eur J Clin Pharmacol; 1989; 37(1):79-84. PubMed ID: 2591469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-independent pharmacokinetics of colchicine after oral administration to healthy volunteers.
    Girre C; Thomas G; Scherrmann JM; Crouzette J; Fournier PE
    Fundam Clin Pharmacol; 1989; 3(5):537-43. PubMed ID: 2606428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are dosing adjustments required for colchicine in the elderly compared with younger patients?
    Wason S; Faulkner RD; Davis MW
    Adv Ther; 2012 Jun; 29(6):551-61. PubMed ID: 22753019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers.
    Zhao JJ; Rogers JD; Holland SD; Larson P; Amin RD; Haesen R; Freeman A; Seiberling M; Merz M; Cheng H
    Biopharm Drug Dispos; 1997 Dec; 18(9):769-77. PubMed ID: 9429741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flumazenil kinetics in the elderly.
    Roncari G; Timm U; Zell M; Zumbrunnen R; Weber W
    Eur J Clin Pharmacol; 1993; 45(6):585-7. PubMed ID: 8157048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.
    Olsson B; Johansson M; Gabrielsson J; Bolme P
    Eur J Clin Pharmacol; 1988; 34(1):77-82. PubMed ID: 3360052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers.
    Sandouk P; Bouvier d'Yvoire M; Chretien P; Tillement JP; Scherrmann JM
    Biopharm Drug Dispos; 1994 Jan; 15(1):87-92. PubMed ID: 8161719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in ten cases.
    Rochdi M; Sabouraud A; Baud FJ; Bismuth C; Scherrmann JM
    Hum Exp Toxicol; 1992 Nov; 11(6):510-6. PubMed ID: 1361141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic men.
    Brandi L; Egfjord M; Olgaard K
    Nephrol Dial Transplant; 2002 May; 17(5):829-42. PubMed ID: 11981071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and pharmacokinetics of oxazepam.
    Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
    Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
    Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
    Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioavailability of oral ergometrine in male volunteers.
    de Groot AN; Vree TB; Hekster YA; van den Biggelaar-Martea M; van Dongen PW; van Roosmalen J
    Biopharm Drug Dispos; 1994 Jan; 15(1):65-73. PubMed ID: 8161717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
    Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man. A study using a stable isotope techique.
    Heikkinen H; Saraheimo M; Antila S; Ottoila P; Pentikäinen PJ
    Eur J Clin Pharmacol; 2001; 56(11):821-6. PubMed ID: 11294372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of benperidol in schizophrenic patients after intravenous and two different kinds of oral application.
    Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Langer M; Barlage U; Hiemke C
    Psychopharmacology (Berl); 1994 Dec; 116(4):457-63. PubMed ID: 7701049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.